These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8236359)

  • 1. Preliminary studies of the effects of extracorporeal membrane oxygenator on the disposition of common pediatric drugs.
    Dagan O; Klein J; Gruenwald C; Bohn D; Barker G; Koren G
    Ther Drug Monit; 1993 Aug; 15(4):263-6. PubMed ID: 8236359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenobarbital dosing and pharmacokinetics in a neonate receiving extracorporeal membrane oxygenation.
    Elliott ES; Buck ML
    Ann Pharmacother; 1999 Apr; 33(4):419-22. PubMed ID: 10332532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphine pharmacokinetics during continuous infusion of morphine sulfate for infants receiving extracorporeal membrane oxygenation.
    Geiduschek JM; Lynn AM; Bratton SL; Sanders JC; Levy FH; Haberkern CM; O'Rourke PP
    Crit Care Med; 1997 Feb; 25(2):360-4. PubMed ID: 9034277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of an
    Kalaria SN; Kishk OA; Gopalakrishnan M; Bagdure DN
    Perfusion; 2022 Nov; 37(8):812-818. PubMed ID: 34192981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic changes during extracorporeal membrane oxygenation: implications for drug therapy of neonates.
    Buck ML
    Clin Pharmacokinet; 2003; 42(5):403-17. PubMed ID: 12739981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin pharmacokinetics in neonates receiving extracorporeal membrane oxygenation.
    Buck ML
    Pharmacotherapy; 1998; 18(5):1082-6. PubMed ID: 9758319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic Assessment of Pre- and Post-Oxygenator Vancomycin Concentrations in Extracorporeal Membrane Oxygenation: A Prospective Observational Study.
    Mahmoud AA; Avedissian SN; Al-Qamari A; Bohling T; Pham M; Scheetz MH
    Clin Pharmacokinet; 2020 Dec; 59(12):1575-1587. PubMed ID: 32468446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sedative clearance during extracorporeal membrane oxygenation.
    Bhatt-Meht V; Annich G
    Perfusion; 2005 Oct; 20(6):309-15. PubMed ID: 16363315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics in critically ill neonates and infants undergoing extracorporeal membrane oxygenation: a literature review.
    Yalcin N; Sürmelioğlu N; Allegaert K
    BMJ Paediatr Open; 2022 Nov; 6(1):. PubMed ID: 36437518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of vancomycin in adults receiving extracorporeal membrane oxygenation.
    Wu CC; Shen LJ; Hsu LF; Ko WJ; Wu FL
    J Formos Med Assoc; 2016 Jul; 115(7):560-70. PubMed ID: 26123638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gentamicin pharmacokinetics in term neonates receiving extracorporeal membrane oxygenation.
    Bhatt-Mehta V; Johnson CE; Schumacher RE
    Pharmacotherapy; 1992; 12(1):28-32. PubMed ID: 1549536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation.
    Shekar K; Roberts JA; Mcdonald CI; Fisquet S; Barnett AG; Mullany DV; Ghassabian S; Wallis SC; Fung YL; Smith MT; Fraser JF
    Crit Care; 2012 Oct; 16(5):R194. PubMed ID: 23068416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of vancomycin in critically ill infants undergoing extracorporeal membrane oxygenation.
    Amaker RD; DiPiro JT; Bhatia J
    Antimicrob Agents Chemother; 1996 May; 40(5):1139-42. PubMed ID: 8723454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxygenator Impact on Ceftolozane and Tazobactam in Extracorporeal Membrane Oxygenation Circuits.
    Cies JJ; Moore WS; Giliam N; Low T; Enache A; Chopra A
    Pediatr Crit Care Med; 2020 Mar; 21(3):276-282. PubMed ID: 31688715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential drug sequestration during extracorporeal membrane oxygenation: results from an ex vivo experiment.
    Mehta NM; Halwick DR; Dodson BL; Thompson JE; Arnold JH
    Intensive Care Med; 2007 Jun; 33(6):1018-24. PubMed ID: 17404709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical pharmacokinetics of anti-infective drugs in extracorporeal membrane oxygenation].
    Reimer A; Vogl H; Schmid S; Gfrörer S; Bürle M; Hoffmann M; Geldner G
    Anaesthesist; 2019 Dec; 68(12):821-826. PubMed ID: 31740986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of extracorporeal membrane oxygenation on morphine pharmacokinetics in infants.
    Dagan O; Klein J; Bohn D; Koren G
    Crit Care Med; 1994 Jul; 22(7):1099-101. PubMed ID: 8026197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphine pharmacokinetics during venoarterial extracorporeal membrane oxygenation in neonates.
    Peters JW; Anderson BJ; Simons SH; Uges DR; Tibboel D
    Intensive Care Med; 2005 Feb; 31(2):257-63. PubMed ID: 15678314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic changes of antibiotic, antiviral, antituberculosis and antifungal agents during extracorporeal membrane oxygenation in critically ill adult patients.
    Hahn J; Choi JH; Chang MJ
    J Clin Pharm Ther; 2017 Dec; 42(6):661-671. PubMed ID: 28948652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin population pharmacokinetics during extracorporeal membrane oxygenation therapy: a matched cohort study.
    Donadello K; Roberts JA; Cristallini S; Beumier M; Shekar K; Jacobs F; Belhaj A; Vincent JL; de Backer D; Taccone FS
    Crit Care; 2014 Nov; 18(6):632. PubMed ID: 25416535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.